005500.KO Samjin Pharm

Healthcare Pharmaceuticals Korea Stock Exchange
20,350 KRW
Close of Nov 5, 2026
16,580 25,900
Market cap
KRW 258B
P/E
11.8x
P/B
0.87x
ROE
5.0%
Dividend yield
3.81%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 005500.KO undervalued?

Graham number
Price20,350
Graham value30,160
Discount32.5%

005500.KO trades 32.5% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Samjin Pharm fundamental analysis

No fundamental analysis for Samjin Pharm yet.

Samjin Pharm stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Samjin Pharm

Samjin Pharmaceuticals Co., Ltd. manufactures and sells medicine. It offers medicine in oral, drop, and injecting forms. The company provides over-the-counter medicines, such as Gevorin, an anti-infalammatory pain killer; Trestan, an appetite stimulant; Flaris, an anti-thrombotic agent; and Nutilin, a brain function improvement agent, as well as medicine for treatment of chronic diseases. It also develops SA001, which is in Phase II clinical trial for the treatment for dry e…

Full company profile